Name: 글로벌 시장 동향
SKU: PH2680
Availability: InStock

보고서 요약(국문)

보고서 개요
글로벌 엑소좀 시장은 2023년 13억 달러에 달했으며, 2024년부터 2031년까지 연평균 15.6%의 성장률을 보이며 2031년에는 27억 달러에 이를 것으로 예상됩니다.
엑소좀은 30~200nm 크기의 작은 소포로, 세포에서 분비되어 종양괴사 인자(TNF)에 의해 유도된 중간엽 줄기세포(TME)에서 신호 전달을 매개합니다. 종양유발성 EGFR은 세포에서 분비되어 다른 TME 세포와 상호작용할 수 있습니다. 위암 세포에서 분비되는 엑소좀은 간 미세환경을 조절하고 간 전이를 촉진할 수 있습니다. EGFR을 함유한 엑소좀은 내피세포에 포착되어 EGFR 의존성 반응과 VEGF 분비를 유도할 수 있습니다. EGFR 변이 비소세포폐암(NSCLC)에서 분비되는 엑소좀은 CD8+ T 세포의 세포사멸을 촉진하여 면역요법의 효능에 영향을 미칠 수 있습니다.

시장 동향: 동인 및 제약 요인
암 발병률 증가
암 발병률 증가는 혁신적인 치료법에 대한 수요 증가로 이어지고 있습니다. 액체 생검과 같은 엑소좀 기반 기술은 혈액, 소변, 타액과 같은 체액에서 바이오마커를 분석하는 데 사용되고 있습니다. 분자 정보를 안정적으로 전달하는 엑소좀은 액체 생검에 이상적인 물질입니다. 연구자들은 질병 진행, 치료 반응, 미세 잔존 질환 탐지를 위한 엑소좀 바이오마커의 활용을 연구하고 있습니다.
예를 들어, 미국 국립보건통계센터(NCHS)에 따르면 2023년 미국에서는 1,958,310건의 새로운 암 환자가 발생하고 609,820명이 암으로 사망할 것으로 예상됩니다. 전립선암 발병률은 20년간 감소세를 보인 후 2014년부터 2019년까지 매년 3%씩 증가하여 99,000건의 새로운 환자가 추가로 발생했습니다. 그러나 다른 암의 경우 남성이 여성보다 발병률 추세가 더 양호했습니다.

엑소좀 분리의 기술적 복잡성 및 기술적 한계
크기, 구성 및 함유 물질로 특징지어지는 엑소좀은 높은 순도와 특이성을 가지고 분리하는 데 기술적인 어려움이 있습니다. 표준화된 방법이 부족하여 실험 결과의 변동성이 발생하고 연구 간 비교 가능성이 저해될 수 있습니다. 다른 세포외 소포 및 오염 물질의 존재로 인해 분리 과정은 기술적으로 까다롭습니다. 순수하고 수율이 높은 엑소좀을 분리하려면 정교한 기술이 필요하며, 이는 얻어진 샘플의 품질과 일관성에 영향을 미칠 수 있습니다.
시장 세분화 분석
글로벌 엑소좀 시장은 제품 유형, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
제품 유형 부문에서 키트 및 시약은 엑소좀 시장 점유율의 약 47.3%를 차지했습니다.
키트 및 시약은 엑소좀 연구 및 임상 응용 분야에서 필수적인 도구입니다. 이러한 도구들은 혈액, 소변, 세포 배양액과 같은 생물학적 시료에서 엑소좀을 분리, 검출 및 분석하는 데 도움을 줍니다. 이러한 도구들은 생물학적 무결성을 유지하면서 높은 수율과 순도를 보장합니다. 키트는 분리 과정을 간소화하여 기술 전문 지식이 부족한 사람들도 쉽게 사용할 수 있도록 합니다. 항체 및 염료와 같은 시약은 엑소좀 표면 마커를 표지하고 검출하여 엑소좀 내용물의 특성을 규명할 수 있도록 합니다. 이는 진단, 특히 암, 신경퇴행성 질환, 심혈관 질환과 같은 질병의 바이오마커를 식별하는 데 매우 중요합니다.
예를 들어, 2023년 7월 시마즈(Shimadzu Corporation)는 다이 니폰 토료(Dai Nippon Toryo Co., Ltd.)에서 출시한 세포외 소포(CD9)용 면역크로마토그래피 키트인 Exorapid-qIC를 개발했는데, 이는 세계 최초로 엑소좀을 표적으로 하는 키트입니다. 이 키트에는 금 나노플레이트로 표지된 항체, 면역크로마토그래피 테스트 용지, 세척액이 포함되어 있습니다. 시마즈는 엑소좀 유형 검출 및 검출 시스템 최적화를 담당합니다.

시장 지역 분석
북미는 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다.
북미는 새로운 바이오마커 발굴을 위한 정부 자금 지원 증가와 심혈관 질환 및 암과 같은 만성 질환 발병률 증가로 인해 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다. 또한, 신약, 진단 방법 및 치료 옵션 개발을 위한 연구 개발 활동 증가가 해당 부문의 성장을 견인할 것으로 예상됩니다.
예를 들어, 신경퇴행성 질환 치료를 위한 신경 엑소좀 기반 치료제 분야의 선두 기업인 아루나 바이오(Aruna Bio)는 2024년 7월, 신경 줄기세포에서 유래한 엑소좀인 AB126이라는 주요 프로그램에 대한 미국 특허 제11,993,787호를 획득했습니다. AB126의 물질 조성 및 AB16을 이용한 유전자 치료 제품에 대한 보호를 확대하는 이 특허는 2038년까지 승인될 것으로 예상됩니다.
시장 세분화
제품 유형별
키트 및 시약
기기
기타
응용 분야별
암 관련 응용 분야
폐암
유방암
전립선암
대장암
기타
비암 관련 응용 분야
최종 사용자별
진단
병원 및 임상 검사 연구소
기타
지역별
북미
미국
캐나다
멕시코
유럽
독일
영국
프랑스
이탈리아
스페인
기타 유럽
남미
브라질
아르헨티나
기타 남미
아시아 태평양
중국
인도
일본
한국
기타 아시아 태평양
중동 및 아프리카
시장 경쟁 환경
시장의 주요 글로벌 업체로는 STARTEK이 있습니다. 주요 기업으로는 Health, Diagenode Inc., Fujifilm Holdings Corporation, Hitachi Chemical Diagnostics Inc., Lonza, MBL International, Miltenyi Biotec, Novus Biologicals, Qiagen, Thermo Fisher Scientific Inc. 등이 있습니다.
주요 개발 사항
2024년 1월, 희귀 질환 치료를 위해 엑소좀을 활용한 바이오 의약품 개발에 주력하는 벨기에 바이오테크 기업 EXO Biologics SA는 엑소좀 전문 위탁 개발 및 제조 조직(CDMO)인 ExoXpert를 설립했습니다. ExoXpert는 유럽 임상 시험에 사용되는 MSC 기반 엑소좀 제조 플랫폼을 제공하며, EXO Biologics의 완전 자회사입니다.
보고서 구매 이유
제품 유형, 응용 분야, 최종 사용자 및 지역별 글로벌 엑소좀 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위해.
트렌드 및 공동 개발 분석을 통해 사업 기회를 식별하기 위해.

모든 세그먼트를 포함한 엑소좀 시장 수준의 다양한 데이터 포인트가 담긴 엑셀 데이터 시트입니다.

PDF 보고서는 철저한 질적 인터뷰와 심층 연구를 바탕으로 한 종합적인 분석 자료입니다.
주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료(엑셀 파일)가 제공됩니다.
글로벌 엑소좀 시장 보고서는 약 64개의 표, 61개의 그림, 186페이지 분량입니다.
주요 고객 (2024년 기준)
제조업체/구매자
산업 투자자/투자은행가
연구 전문가
신흥 기업

보고서 요약(영어 원문)

Report Overview
Global Exosomes Market reached US$ 1.3 billion in 2023 and is expected to reach US$ 2.7 billion by 2031, growing at a CAGR of 15.6% during the forecast period 2024-2031
Exosomes, small vesicles 30 to 200 nm, are secreted from cells to mediate signaling in the tumor necrosis factor (TNF)-induced mesenchymal stem cells (TME). Oncogenic EGFR can be shed from cells and interact with other TME cells. Exosomes from gastric cancer cells can regulate the liver microenvironment and promote liver metastasis. EGFR-containing exosomes can be captured by endothelial cells, eliciting EGFR-dependent responses and VEGF secretion. Exosomes from EGFR-mutated NSCLC can promote CD8+ T cell apoptosis, potentially affecting immunotherapy efficacy.
Market Dynamics: Drivers & Restraints
Rise in the prevalence of cancers.
The increasing prevalence of cancer has led to a growing demand for innovative therapies. Exosome-based technologies, such as liquid biopsy, are being used to analyze biomarkers in bodily fluids like blood, urine, or saliva. Exosomes, as stable carriers of molecular information, are ideal candidates for liquid biopsy approaches. Researchers are exploring the use of exosomal biomarkers for disease progression, treatment response, and detecting minimal residual disease.
For instance, according to the National Center for Health Statistics, In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Cancer incidence increased for prostate cancer by 3% annually from 2014 through 2019 after two decades of decline, translating to an additional 99,000 new cases; otherwise, however, incidence trends were more favorable in men compared to women.
Technical complexity of exosome isolation and technological limitations
Exosomes, characterized by their size, composition, and cargo, present a technical challenge in isolating them with high purity and specificity. The absence of standardized methods can lead to variability in experimental outcomes and hinder comparability between studies. The isolation process is technically demanding due to the presence of other extracellular vesicles and contaminants. Obtaining pure and high-yield exosome isolation requires sophisticated techniques, which can affect the quality and consistency of the obtained samples.
Market Segment Analysis
The global exosomes market is segmented based on product type, application, end-user, and region.
The kits and reagents from the product type segment accounted for approximately 47.3% of the exosomes market share
The kits and reagents from the product type segment accounted for approximately 47.3%. Kits and reagents are essential tools in exosome research and clinical applications. They facilitate the isolation, detection, and analysis of exosomes from biological samples like blood, urine, and cell culture media. These tools ensure high yield and purity while preserving biological integrity. Kits simplify the isolating process, making it accessible to those with limited technical expertise. Reagents, like antibodies and dyes, label and detect exosomal surface markers, enabling the characterization of exosome cargo. This is crucial for diagnostics, particularly in identifying biomarkers for diseases like cancer, neurodegenerative disorders, and cardiovascular conditions.
For instance, in July 2023, Shimadzu Corporation developed Exorapid-qIC, an immunochromatography kit for extracellular vesicles (CD9) launched by Dai Nippon Toryo Co., Ltd., it is the world's first kit targeting exosomes. The kit includes gold nanoplate-labeled antibodies, immunochromatography test paper, and rinse solution. Shimadzu is responsible for detecting EV types and optimizing the detection system.
Market Geographical Analysis
North America is estimated to hold about 38.4% of the total market share throughout the forecast period
North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to the rising government funding for the detection of new biomarkers and the increasing incidence of chronic conditions, such as cardiovascular diseases and cancer. In addition, growing research & development activities for the development of novel drugs, diagnostic methods, and treatment options are anticipated to drive the segment growth.
For instance, in July 2024, Aruna Bio, a leader in neural exosome-based therapeutics for neurodegenerative conditions, received a US Patent No. 11,993,787 for its lead program, AB126, an exosome derived from neural stem cells. The patent, which extends protection covering the composition of matter for AB126 and products for gene therapy using AB16, is expected to be granted by 2038.
Market Segmentation
By Product Type
Kits and Reagents
Instruments
Others
By Application
Cancer Applications
Lung Cancer
Breast Cancer
Prostate Cancer
Colorectal Cancer
Other
Non-Cancer Applications
By End User
Diagnostics
Hospitals & Clinical Testing Laboratories
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Middle East and Africa
Market Competitive Landscape
The major global players in the market include STARTEK Health, Diagenode Inc., Fujifilm Holdings Corporation, Hitachi Chemical Diagnostics Inc., Lonza, MBL International, Miltenyi Biotec, Novus Biologicals, Qiagen, Thermo Fisher Scientific Inc. among others.
Key Developments
In January 2024, EXO Biologics SA, a Belgian biotech company committed to developing biopharmaceuticals using exosomes to treat rare diseases with high unmet medical needs, launched ExoXpert, a contract development and manufacturing organization (CDMO) specializing in exosomes. ExoXpert offers an MSC-based exosome manufacturing platform used in European clinical trials and is a wholly-owned subsidiary of EXO Biologics.
Why Purchase the Report?
To visualize the global exosomes market segmentation based on product type, application, end-user, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the exosomes market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.
The global exosomes market report would provide approximately 64 tables, 61 figures, and 186 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the prevalence of cancer
4.1.1.2. Increasing focus on personalized medicine
4.1.2. Restraints
4.1.2.1. Technical complexity of exosome isolation and technological limitations
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Kits and Reagents*
6.2.1. Introduction
6.3. Instruments
6.4. Others
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.2. Market Attractiveness Index, By Application
7.3. Cancer Applications*
7.3.1. Introduction
7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.4. Non-Cancer Applications
8. By End User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
8.1.2. Market Attractiveness Index, By End User
8.2. Diagnostics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hospitals & Clinical Testing Laboratories
8.4. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. UK
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. STARTEK Health*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Diagenode Inc
11.3. Fujifilm Holdings Corporation
11.4. Hitachi Chemical Diagnostics Inc
11.5. Lonza
11.6. MBL International
11.7. Miltenyi Biotec
11.8. Novus Biologicals
11.9. Qiagen
11.10. Thermo Fisher Scientific Inc (*LIST NOT EXHAUSTIVE)
12. Appendix
12.1. About Us and Services
12.2. Contact Us

언급된 주요 기업들

STARTEK Health, 4.	Key Developments, Diagenode Inc, Fujifilm Holdings Corporation, Hitachi Chemical Diagnostics Inc, Lonza, MBL International, Miltenyi Biotec, Novus Biologicals, Qiagen

표 목록 (Tables)

List of Tables

Table 1 Global Exosomes Market Value, By Product Type, 2025, 2029 & 2033 (US$ Million)

Table 2 Global Exosomes Market Value, By Method, 2025, 2029 & 2033 (US$ Million)

Table 3 Global Exosomes Market Value, By Application, 2025, 2029 & 2033 (US$ Million)

Table 4 Global Exosomes Market Value, By End User, 2025, 2029 & 2033 (US$ Million)

Table 5 Global Exosomes Market Value, By Region, 2025, 2029 & 2033 (US$ Million)

Table 6 Global Exosomes Market Value, By Product Type, 2025, 2029 & 2033 (US$ Million)

Table 7 Global Exosomes Market Value, By Product Type, 2022-2033 (US$ Million)

Table 8 Global Exosomes Market Value, By Method, 2025, 2029 & 2033 (US$ Million)

Table 9 Global Exosomes Market Value, By Method, 2022-2033 (US$ Million)

Table 10 Global Exosomes Market Value, By Application, 2025, 2029 & 2033 (US$ Million)

Table 11 Global Exosomes Market Value, By Application, 2022-2033 (US$ Million)

Table 12 Global Exosomes Market Value, By End User, 2025, 2029 & 2033 (US$ Million)

Table 13 Global Exosomes Market Value, By End User, 2022-2033 (US$ Million)

Table 14 Global Exosomes Market Value, By Region, 2025, 2029 & 2033 (US$ Million)

Table 15 Global Exosomes Market Value, By Region, 2022-2033 (US$ Million)

Table 16 North America Exosomes Market Value, By Product Type, 2022-2033 (US$ Million)

Table 17 North America Exosomes Market Value, By Method, 2022-2033 (US$ Million)

Table 18 North America Exosomes Market Value, By Application, 2022-2033 (US$ Million)

Table 19 North America Exosomes Market Value, By End User, 2022-2033 (US$ Million)

Table 20 North America Exosomes Market Value, By Country, 2022-2033 (US$ Million)

Table 21 Europe Exosomes Market Value, By Product Type, 2022-2033 (US$ Million)

Table 22 Europe Exosomes Market Value, By Method, 2022-2033 (US$ Million)

Table 23 Europe Exosomes Market Value, By Application, 2022-2033 (US$ Million)

Table 24 Europe Exosomes Market Value, By End User, 2022-2033 (US$ Million)

Table 25 Europe Exosomes Market Value, By Country, 2022-2033 (US$ Million)

Table 26 Asia-Pacific Exosomes Market Value, By Product Type, 2022-2033 (US$ Million)

Table 27 Asia-Pacific Exosomes Market Value, By Method, 2022-2033 (US$ Million)

Table 28 Asia-Pacific Exosomes Market Value, By Application, 2022-2033 (US$ Million)

Table 29 Asia-Pacific Exosomes Market Value, By End User, 2022-2033 (US$ Million)

Table 30 Asia-Pacific Exosomes Market Value, By Country, 2022-2033 (US$ Million)

Table 31 South America Exosomes Market Value, By Product Type, 2022-2033 (US$ Million)

Table 32 South America Exosomes Market Value, By Method, 2022-2033 (US$ Million)

Table 33 South America Exosomes Market Value, By Application, 2022-2033 (US$ Million)

Table 34 South America Exosomes Market Value, By End User, 2022-2033 (US$ Million)

Table 35 South America Exosomes Market Value, By Country, 2022-2033 (US$ Million)

Table 36 Middle East and Africa Exosomes Market Value, By Product Type, 2022-2033 (US$ Million)

Table 37 Middle East and Africa Exosomes Market Value, By Method, 2022-2033 (US$ Million)

Table 38 Middle East and Africa Exosomes Market Value, By Application, 2022-2033 (US$ Million)

Table 39 Middle East and Africa Exosomes Market Value, By End User, 2022-2033 (US$ Million)

Table 40 Middle East and Africa Exosomes Market Value, By Country, 2022-2033 (US$ Million)

Table 41 Thermo Fisher Scientific Inc: Overview

Table 42 Thermo Fisher Scientific Inc: Product Portfolio

Table 43 Thermo Fisher Scientific Inc: Key Developments

Table 44 Qiagen: Overview

Table 45 Qiagen: Product Portfolio

Table 46 Qiagen: Key Developments

Table 47 Beckman Coulter, Inc: Overview

Table 48 Beckman Coulter, Inc: Product Portfolio

Table 49 Beckman Coulter, Inc: Key Developments

Table 50 Diagenode Inc.: Overview

Table 51 Diagenode Inc.: Product Portfolio

Table 52 Diagenode Inc.: Key Developments

Table 53 Fujifilm Holdings Corporation: Overview

Table 54 Fujifilm Holdings Corporation: Product Portfolio

Table 55 Fujifilm Holdings Corporation: Key Developments

Table 56 Lonza: Overview

Table 57 Lonza: Product Portfolio

Table 58 Lonza: Key Developments

Table 59 Miltenyi Biotec: Overview

Table 60 Miltenyi Biotec: Product Portfolio

Table 61 Miltenyi Biotec: Key Developments

Table 62 Novus Biologicals: Overview

Table 63 Novus Biologicals: Product Portfolio

Table 64 Novus Biologicals: Key Developments

Table 65 Capital Biosciences: Overview

Table 66 Capital Biosciences: Product Portfolio

Table 67 Capital Biosciences: Key Developments

Table 68 Bio Techne: Overview

Table 69 Bio Techne: Product Portfolio

Table 70 Bio Techne: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 2 Global Exosomes Market Share, By Product Type, 2024 & 2033 (%)

Figure 3 Global Exosomes Market Share, By Method, 2024 & 2033 (%)

Figure 4 Global Exosomes Market Share, By Application, 2024 & 2033 (%)

Figure 5 Global Exosomes Market Share, By End User, 2024 & 2033 (%)

Figure 6 Global Exosomes Market Share, By Region, 2024 & 2033 (%)

Figure 7 Global Exosomes Market Y-o-Y Growth, By Product Type, 2023-2033 (%)

Figure 8: Kits and Reagents Exosomes Market Value, 2022-2033 (US$ Million)

Figure 9 Instruments Exosomes Market Value, 2022-2033 (US$ Million)

Figure 10 Services Exosomes Market Value, 2022-2033 (US$ Million)

Figure 11 Global Exosomes Market Y-o-Y Growth, By Method, 2023-2033 (%)

Figure 12 Differential Ultracentrifugation Method in Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 13 Density Gradient Centrifugation Method in Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 14 Ultrafiltration Method in Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 15: Other Methods in Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 16 Global Exosomes Market Y-o-Y Growth, By Application, 2023-2033 (%)

Figure 17 Cancer Application in Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 18 Neurodegenerative Diseases Application in Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 19 Cardiovascular Diseases Application in Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 20 Infectious Diseases Application in Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 21 Biomarker Discovery Application in Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 22 Drug Delivery Research Application in Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 23 Others Application in Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 24 Global Exosomes Market Y-o-Y Growth, By End User, 2023-2033 (%)

Figure 25 Hospitals End User in Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 26 Clinics End User in Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 27 Pharmaceutical and Biotechnology Companies End User in Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 28: Other End User in Global Exosomes Market Value, 2022-2033 (US$ Million)

Figure 29 Global Exosomes Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 30 North America Exosomes Market Value, 2022-2033 (US$ Million)

Figure 31 North America Exosomes Market Share, By Product Type, 2024 & 2033 (%)

Figure 32 North America Exosomes Market Share, By Method, 2024 & 2033 (%)

Figure 33 North America Exosomes Market Share, By Application, 2024 & 2033 (%)

Figure 34 North America Exosomes Market Share, By End User, 2024 & 2033 (%)

Figure 35 North America Exosomes Market Share, By Country, 2024 & 2033 (%)

Figure 36 Europe Exosomes Market Value, 2022-2033 (US$ Million)

Figure 37 Europe Exosomes Market Share, By Product Type, 2024 & 2033 (%)

Figure 38 Europe Exosomes Market Share, By Method, 2024 & 2033 (%)

Figure 39 Europe Exosomes Market Share, By Application, 2024 & 2033 (%)

Figure 40 Europe Exosomes Market Share, By End User, 2024 & 2033 (%)

Figure 41 Europe Exosomes Market Share, By Country, 2024 & 2033 (%)

Figure 42 Asia-Pacific Exosomes Market Value, 2022-2033 (US$ Million)

Figure 43 Asia-Pacific Exosomes Market Share, By Product Type, 2024 & 2033 (%)

Figure 44 Asia-Pacific Exosomes Market Share, By Method, 2024 & 2033 (%)

Figure 45 Asia-Pacific Exosomes Market Share, By Application, 2024 & 2033 (%)

Figure 46 Asia-Pacific Exosomes Market Share, By End User, 2024 & 2033 (%)

Figure 47 Asia-Pacific Exosomes Market Share, By Country, 2024 & 2033 (%)

Figure 48 South America Exosomes Market Value, 2022-2033 (US$ Million)

Figure 49 South America Exosomes Market Share, By Product Type, 2024 & 2033 (%)

Figure 50 South America Exosomes Market Share, By Method, 2024 & 2033 (%)

Figure 51 South America Exosomes Market Share, By Application, 2024 & 2033 (%)

Figure 52 South America Exosomes Market Share, By End User, 2024 & 2033 (%)

Figure 53 South America Exosomes Market Share, By Country, 2024 & 2033 (%)

Figure 54 Middle East and Africa Exosomes Market Value, 2022-2033 (US$ Million)

Figure 55 Middle East and Africa Exosomes Market Share, By Product Type, 2024 & 2033 (%)

Figure 56 Middle East and Africa Exosomes Market Share, By Method, 2024 & 2033 (%)

Figure 57 Middle East and Africa Exosomes Market Share, By Application, 2024 & 2033 (%)

Figure 58 Middle East and Africa Exosomes Market Share, By End User, 2024 & 2033 (%)

Figure 59 Thermo Fisher Scientific Inc: Financials

Figure 60 Qiagen: Financials

Figure 61 Beckman Coulter, Inc.: Financials

Figure 62 Diagenode Inc.: Financials

Figure 63 Fujifilm Holdings Corporation: Financials

Figure 64 Lonza: Financials

Figure 65: Miltenyi Biotec: Financials

Figure 66 Novus Biologicals: Financials

Figure 67 Capital Biosciences: Financials

Figure 68 Bio Techne: Financials

글로벌 엑소좀 시장 – 2024년 – 2031년

Global Exosomes Market - 2024 - 2031